Skip to main content
SpringerLink
Log in

Modulation of 5-fluorouracil by interferon: a review of potential cellular targets

  • Papers
  • Published:
Medical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wadler, S. and Schwartz, E.L. (1990) Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.Cancer Res. 50, 3486.

    Google Scholar 

  2. Wadler, S., Wersto, R., Weinberg, V., Thompson, D. and Schwartz, E.L. (1990) Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects.Cancer Res. 50, 3735–9.

    Google Scholar 

  3. Sparano, J.A., Wadler, S., Schwartz, E.L. and Diasio, R. (1993) Clinical and pharmacological studies of interferon and chemotherapy in gastrointestinal and breast cancer.Int. J. Clin. Pharm. Res. 13, 1–9.

    CAS  Google Scholar 

  4. Dolnick, B.J. and Pink, J.J. (1985) Effects of 5-fluorouracil on dihydrofolate reductase mRNA from methotrexate-resistant KB cells.J. Biol. Chem. 260, 3006–14.

    PubMed  CAS  Google Scholar 

  5. Kufe, D.W., Major, P.P., Egan, E.M. and Loh, E. (1981) 5-Fluoro-2′-deoxyuridine incorporation into L1210 DNA.J. Biol. Chem. 256, 8885–8.

    PubMed  CAS  Google Scholar 

  6. Mauro, D.J., De Riel, J.K., Tallarida, R.J. and Sirover, M.A. (1993) Mechanisms of excision of 5-fluorouracil by uracil DNA glycosylase in normal human cells.Mol. Pharmacol. 43, 854–7.

    PubMed  CAS  Google Scholar 

  7. Moran, R.G., Spears, C.P. and Heidelberger, C. (1979) Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for determination of 5-fluoro-2′-deoxyuridylate, 2′-deoxyuridylate and thymidylate synthetase.Proc. Natl. Acad. Sci. USA 76, 1456–60.

    Article  PubMed  CAS  Google Scholar 

  8. Goulian, M., Bleile, B.M., Dickey, L.M., Grafstrom, R.H., Ingraham, H.A., Neynaber, S.A., Peterson, M.S. and Tseng, B.Y. (1986) Mechanism of thymineless death.Adv. Exp. Med. Biol. 195, 89–95.

    PubMed  Google Scholar 

  9. Yoshioka, A., Tanaka, S., Osamu, H., Koyama, Y., Hirota, Y., Ayusawa, D., Seno, T., Garrett, C. and Wataya, Y. (1987) Deoxynucleoside triphosphate imbalance.J. Biol. Chem. 262, 8235–4.

    PubMed  CAS  Google Scholar 

  10. Peters, G.J., van der Wilt, C.L., van Groeningen, C.J., Smid, K., Meijer, S. and Pinedo, H.M. (1994) Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil.J. Clin. Oncol. 12, 2035–42.

    PubMed  CAS  Google Scholar 

  11. Aschele, C., Sobrero, A., Faderan, M.A. and Bertino, J.R. (1992) Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules.Cancer Res. 52, 1855–64.

    PubMed  CAS  Google Scholar 

  12. Chu, E., Zinn, S., Boarman, D. and Allegra, C.J. (1990) Interaction of γ interferon and 5-fluorouracil in the H630 human colon carcinoma cell line.Cancer Res. 50, 5834–5840.

    PubMed  CAS  Google Scholar 

  13. Schwartz, E.L., Baptiste, N., O’Connor, C.J., Wadler, S. and Otter, B.A. (1994) Potentiation of the antitumor activity of interferon and deoxynucleosides results from complementary effects on thymidine phosphorylase.Cancer Res. 54, 1472–8.

    PubMed  CAS  Google Scholar 

  14. Lonn, U., Lonn, S., Nylen, U. and Winblad, G. (1989) 5-Fluoropyrimidine-induced DNA damage in human colon adenocarcinoma and its augmentation by the nucleoside transport inhibitor dipyridamole.Cancer Res. 49, 1085–9.

    PubMed  CAS  Google Scholar 

  15. Houghton, J.A., Morton, C.L., Adkins, D.A. and Rahman, A. (1993) Locus of the interaction among 5-fluorouracil, leucovorin, and interferon α2a in colon carcinoma cells.Cancer Res. 53, 4243–50.

    PubMed  CAS  Google Scholar 

  16. Yin, M.B. and Rustum, Y.M. (1991) Comparative DNA strand breakage induced by FUra and FdUrd in human ileocecal adenocarcinoma (HCT-8) Cells: relevance to cell growth inhibition.Cancer Commun. 3, 45–51.

    PubMed  CAS  Google Scholar 

  17. Ayusawa, D., Shimizu, K., Koyama, H., Takeishi, K. and Seno, T. (1983) Accumulation of DNA strand breaks during dThd-less death in thymidylate synthase-negative mutants of mouse FM3A cells.J. Biol. Chem. 258, 12448–54.

    PubMed  CAS  Google Scholar 

  18. Curtin, N.J., Harris, A.L. and Aherne, G.W. (1991) Mechanism of cell death following thymidylate synthase inhibition: 2′-deoxyuridine-5′-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyrdamole.Cancer Res. 51, 2346–52.

    PubMed  CAS  Google Scholar 

  19. Dusenbury, C.E., Davis, M.A., Lawrence, T.S. and Maybaum, J. (1991) Induction of megabase DNA fragments by 5-fluorodeoxyuridine in human colorectal tumor (HT29) cells.Molec. Pharmacol. 39, 285–9.

    CAS  Google Scholar 

  20. Harris, B.E., Song, R., Soong, S. and Diasio, R.B. (1990) Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted infusion.Cancer Res. 50, 197–201.

    PubMed  CAS  Google Scholar 

  21. Hyrniuk, W.M., Figueredo, A. and Goodyear, M. (1987) Applications of dose intensity to problems in chemotherapy of breast and colorectal cancer.Semin. Oncol. 14 (suppl 4), 3–11.

    Google Scholar 

  22. Sparano, J.A., Wadler, S., Diasio, R.B., Zhang, R., Lu, Z., Schwartz, E.L., Einzig, A. and Wiernik, P.H. (1993) Phase 1 trial of low-dose, prolonged continuous infusion fluorouracil plus interferon-alfa: evidence for enhanced fluorouracil toxicity without pharmacokinetic perturbation.J. Clin. Oncol. 11, 1609–17.

    PubMed  CAS  Google Scholar 

  23. Schwartz, E.L., Hoffman, M., O’Connor, C.J. and Wadler, S. (1992) Stimulation of 5-fluorouracil metabolic activation by interferon-a in human colon carcinoma cells.Biochem. Biophys. Res. Commun. 182, 1232–39.

    Article  PubMed  CAS  Google Scholar 

  24. Yee, L.K., Allegra, C.J., Steinberg, S.M. and Grem, J.L. (1992) Decreased catabolism of fluorouracil in peripheral blood mononuclear cells during combination therapy with fluorouracil, leucovorin, and interferon α-2a.J. Natl. Cancer Inst. 84, 820–5.

    Article  Google Scholar 

  25. Schuller, J., Czejka, M., Schernthaner, G., Fogl, U., Jager, W. and Micksche, M. (1992) Influence of interferon alpha-2b with or without folinic acid on pharmacokinetics of fluorouracil.Semin. Oncol. 19 (suppl 3), 93–7.

    PubMed  CAS  Google Scholar 

  26. Grem, J.L., McAtee, N., Murphy, R.F., Balis, F.M., Steinberg, S.M., Hamilton, J.M., Sorensen, J.M., Sartor, O., Kramer, B.S., Goldstein, L.J., Gay, L.M., Cuabo, K.M., Goldspiel, B. and Allegra, C.J. (1991) A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma.J. Clin. Oncol. 9, 1811–20.

    PubMed  CAS  Google Scholar 

  27. Lindley, C., Bernard, S. and Gavigan, M. (1990) Interferon-α increases 5-fluorouracil (5-FU) plasma levels 16-fold within one hour: results of a phase 1 study.J. Interferon. Res. 10, S132.

    Google Scholar 

  28. Danhauser, L., Gilchrist, T., Friemann, J., Markowitz, A., Yeomans, A., Hunter, C. and Gutterman, J. (1991) Effect of recombinant interferon-α2b on the plasma pharmacokinetics of fluorouracil in patients with advanced cancer.Proc. Am. Ass. Cancer Res. 32, 1052.

    Google Scholar 

  29. Pittman, K., Perren, T., Ward, U., Primrose, J., Slevin, M., Patel, N. and Selby, P. (1993) Pharmacokinetics of 5-fluorouracil in colorectal cancer patients receiving interferon.Ann. Oncol. 4, 515–6.

    PubMed  CAS  Google Scholar 

  30. Hoffman, M., Wadler, S., Schwartz, E.L. and Wiernik, P.H. (1990) Effects of recombinant interferon-α on anabolism of (6-H3) 5-fluorouracil in human colon cancer cell lines.Proc. Am. Assoc. Cancer Res. 31, 2421.

    Google Scholar 

  31. Yoshimuro, A., Kuwazuru, Y., Furukawa, T., Yoshida, H., Yamada, K. and Akiyama, S.I. (1990) Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes, and tumors.Biochim. Biophys. Acta 1034, 107–13.

    Google Scholar 

  32. Pfeffer, L.M. and Tamm, I. (1984) Interferon Inhibition of Thymidine incorporation in DNA through effects of thymidine transport and uptake.J. Cell. Phys. 121, 431–6.

    Article  CAS  Google Scholar 

  33. Tevaearai, H.T., Laurent, P.L., Suardet, L., Eliason, J.F., Givel, J.C. and Odartchenko, N. (1992) Interactions of interferon α2a with 5′-deoxy-5-fluorouridine in colorectal cancer cellsin vitro.Eur. J. Cancer 28, 368–72.

    Article  PubMed  CAS  Google Scholar 

  34. Eda, H., Fujimoto, K., Watanabe, S.I., Ura, M., Hino, A., Tanaka, Y., Wada, K. and Ishitsuka, H. (1993) Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine.Cancer Chemother. Pharm. 32, 333–8.

    Article  CAS  Google Scholar 

  35. Schwartz, E.L., Baptiste, N. and Wadler, S. (1994) Mechanism of induction of thymidine phosphorylase expression by IFNαin vitro andin vivo.Proc. AACR 35, 318.

    Google Scholar 

  36. Jenh, C.H., Geyer, P.K. and Johnson, L.F. (1985) Control of thymidylate synthase mRNA content and gene transcription in an overproducing mouse cell line.Molec. Cell Biol. 5, 2527–32.

    PubMed  CAS  Google Scholar 

  37. Chu, E., Koeller, D.M., Casey, J.L., Drake, J.C., Chabner, B.A., Elwood, P.C., Zinn, S. and Allegra, C.J. (1991) Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase.Proc. Natl. Acad. Sci. USA 88, 8977–81.

    Article  PubMed  CAS  Google Scholar 

  38. Keyomarsi, K., Samet, J., Molnar, G. and Pardee, A.B. (1993) The thymidylate synthase inhibitor, ICI D1694, overcomes translational detainment of the enzyme.J. Biol. Chem. 268, 15142–9.

    PubMed  CAS  Google Scholar 

  39. Houghton, J.A., Adkins, D.A., Rahman, A. and Houghton, P.J. (1991) Interaction between 5-fluorouracil, [6RS] leucovorin, and recombinant human interferon-α2a in cultured colon adenocarcinoma cells.Cancer Commun. 3, 225–31.

    PubMed  CAS  Google Scholar 

  40. Gewert, D.R., Shah, S. and Clemens, N.J. (1981) Inhibition of cell division by interferons: changes in the transport and intracellular metabolism of thymidine in human lymphoblastoid cells.Eur. J. Biochem. 116, 487–92.

    Article  PubMed  CAS  Google Scholar 

  41. Tanaka, M., Kimura, K. and Yoshida, S. (1987) Inhibition of mammalian DNA polymerases by recombinant α-interferon and γ-interferon.Cancer Res. 47, 5971–4.

    PubMed  CAS  Google Scholar 

  42. Reiter, Z., Ozes, O.N., Blatt, L.M. and Taylor, M.W. (1992) A dual anti-tumor effect of a combination of interferon-α or IL-2 and 5-fluorouracil on natural killer (NK) cell-mediated cytotoxicity.Clin. Immunol. Immunopathol. 62, 103–11.

    Article  PubMed  CAS  Google Scholar 

  43. Morikawa, K., Fan, D., Denkins, Y.M., Levin, B., Gutterman, J.U., Walker, S.M. and Fidler, I.J. (1989) Mechanisms of combined effects of γ-interferon and 5-fluorouracil on human colon cancers implanted into nude mice.Cancer Res. 49, 799–805.

    PubMed  CAS  Google Scholar 

  44. Sidky, Y. and Borden, E. (1987) Inhibition of angiogenesis by interferon: effects on tumor- and lymphocyte-induced vascular responses.Cancer Res. 47, 5155–61.

    PubMed  CAS  Google Scholar 

  45. Furukawa, T., Yoshimura, A. and Sumizawa, T. (1992) Angiogenic factor.Nature 356, 668.

    Article  PubMed  CAS  Google Scholar 

  46. Moghaddam, A. and Bicknell, R. (1992) Expression of platelet-derived endothelial cell growth factorin E. Coli and confirmation of its thymidine phosphorylase activity.Biochemistry 31, 12141–6.

    Article  PubMed  CAS  Google Scholar 

  47. Wadler, S., Mao, X. and Schwartz, E.L. (1992) Recombinant alfa-2a-interferon augments 5-fluorouracil effects on nucleotide pools and DNA double strand breaks in human colon cancer cell lines.Proc. Am. Ass. Cancer Res. 33, 425.

    Google Scholar 

  48. Horrowitz, R.W., Hu, X.P., Schwartz, E.L. and Wadler, S. (1995) Modulation of 5-fluorouracil by interferon-α increases the incidence of DNA double-strand breaks in colon carcinoma cells.Proc. Am. Ass. Cancer Res. 36, 288.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Albert Einstein Cancer Center and the Department of Oncology, Montefiore Medical Center, 10467, Bronx, New York, USA

    Robert Horowitz, Edward L. Schwartz & Scott Wadler

Authors
  1. Robert Horowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edward L. Schwartz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Scott Wadler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horowitz, R., Schwartz, E.L. & Wadler, S. Modulation of 5-fluorouracil by interferon: a review of potential cellular targets. Med Oncol 12, 3–8 (1995). https://doi.org/10.1007/BF01571402

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01571402

Keywords

Search

Navigation